Structure

Physi-Chem Properties

Molecular Weight:  274.12
Volume:  289.565
LogP:  3.499
LogD:  2.921
LogS:  -3.619
# Rotatable Bonds:  5
TPSA:  16.13
# H-Bond Aceptor:  2
# H-Bond Donor:  0
# Rings:  2
# Heavy Atoms:  3

MedChem Properties

QED Drug-Likeness Score:  0.824
Synthetic Accessibility Score:  2.471
Fsp3:  0.312
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.328
MDCK Permeability:  1.181614788947627e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.002
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.96
Plasma Protein Binding (PPB):  76.2685775756836%
Volume Distribution (VD):  3.941
Pgp-substrate:  28.54267692565918%

ADMET: Metabolism

CYP1A2-inhibitor:  0.097
CYP1A2-substrate:  0.947
CYP2C19-inhibitor:  0.055
CYP2C19-substrate:  0.979
CYP2C9-inhibitor:  0.012
CYP2C9-substrate:  0.376
CYP2D6-inhibitor:  0.951
CYP2D6-substrate:  0.909
CYP3A4-inhibitor:  0.026
CYP3A4-substrate:  0.917

ADMET: Excretion

Clearance (CL):  6.299
Half-life (T1/2):  0.073

ADMET: Toxicity

hERG Blockers:  0.471
Human Hepatotoxicity (H-HT):  0.647
Drug-inuced Liver Injury (DILI):  0.122
AMES Toxicity:  0.03
Rat Oral Acute Toxicity:  0.942
Maximum Recommended Daily Dose:  0.922
Skin Sensitization:  0.21
Carcinogencity:  0.052
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.961

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC32002

Natural Product ID:  NPC32002
Common Name*:   Chlorphenamine Maleate
IUPAC Name:   (E)-but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
Synonyms:  
Standard InCHIKey:  DBAKFASWICGISY-WLHGVMLRSA-N
Standard InCHI:  InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
SMILES:  CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C.OC(=O)/C=C/C(=O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL180454
PubChem CID:   6433151
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000089] Pyridines and derivatives
        • [CHEMONTID:0000184] Pheniramines

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8070 Chlorpheniramini maleas n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO8070 Chlorpheniramini maleas n.a. n.a. n.a. n.a. n.a. n.a. Database[TCMID]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT65 Cell Line HepG2 Homo sapiens Potency n.a. 5623.4 nM PMID[536210]
NPT154 Individual Protein Mothers against decapentaplegic homolog 3 Homo sapiens Potency n.a. 6309.6 nM PMID[536210]
NPT10 Individual Protein Geminin Homo sapiens Potency n.a. 920.0 nM PMID[536210]
NPT101 Individual Protein Glucagon-like peptide 1 receptor Homo sapiens Potency n.a. 10000.0 nM PMID[536210]
NPT2 Others Unspecified Potency n.a. 11220.2 nM PMID[536210]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 5.64 % PMID[536211]
NPT20556 SINGLE PROTEIN Replicase polyprotein 1ab Severe acute respiratory syndrome coronavirus 2 Inhibition = 1.683 % PMID[536212]
NPT20555 ORGANISM SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Inhibition = 0.18 % PMID[536213]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC32002 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC315348
0.8707 High Similarity NPC476464
0.8451 Intermediate Similarity NPC316811
0.8442 Intermediate Similarity NPC116961
0.844 Intermediate Similarity NPC314102
0.844 Intermediate Similarity NPC251722
0.8344 Intermediate Similarity NPC477591
0.8333 Intermediate Similarity NPC91958
0.8258 Intermediate Similarity NPC297486
0.8258 Intermediate Similarity NPC240136
0.8258 Intermediate Similarity NPC471402
0.8207 Intermediate Similarity NPC476454
0.8182 Intermediate Similarity NPC471312
0.8162 Intermediate Similarity NPC46358
0.8102 Intermediate Similarity NPC476322
0.8088 Intermediate Similarity NPC329825
0.806 Intermediate Similarity NPC143603
0.8056 Intermediate Similarity NPC150259
0.8029 Intermediate Similarity NPC290094
0.8015 Intermediate Similarity NPC265605
0.8015 Intermediate Similarity NPC182570
0.8015 Intermediate Similarity NPC48564
0.7958 Intermediate Similarity NPC256893
0.7895 Intermediate Similarity NPC470233
0.7887 Intermediate Similarity NPC282398
0.7887 Intermediate Similarity NPC69914
0.7863 Intermediate Similarity NPC27802
0.7857 Intermediate Similarity NPC202957
0.7857 Intermediate Similarity NPC169625
0.7829 Intermediate Similarity NPC40070
0.7823 Intermediate Similarity NPC73767
0.7817 Intermediate Similarity NPC475105
0.7817 Intermediate Similarity NPC476131
0.7817 Intermediate Similarity NPC329896
0.7817 Intermediate Similarity NPC475090
0.7815 Intermediate Similarity NPC470111
0.7786 Intermediate Similarity NPC166424
0.7786 Intermediate Similarity NPC245244
0.7786 Intermediate Similarity NPC146373
0.777 Intermediate Similarity NPC469783
0.777 Intermediate Similarity NPC469768
0.777 Intermediate Similarity NPC469780
0.777 Intermediate Similarity NPC469779
0.777 Intermediate Similarity NPC469761
0.777 Intermediate Similarity NPC469767
0.777 Intermediate Similarity NPC469784
0.7755 Intermediate Similarity NPC169433
0.7746 Intermediate Similarity NPC89490
0.7721 Intermediate Similarity NPC81561
0.7718 Intermediate Similarity NPC469766
0.7708 Intermediate Similarity NPC101165
0.7703 Intermediate Similarity NPC110126
0.7687 Intermediate Similarity NPC84911
0.7647 Intermediate Similarity NPC476566
0.7647 Intermediate Similarity NPC148140
0.7643 Intermediate Similarity NPC56765
0.7636 Intermediate Similarity NPC314919
0.7634 Intermediate Similarity NPC231655
0.7634 Intermediate Similarity NPC76540
0.7619 Intermediate Similarity NPC261195
0.7619 Intermediate Similarity NPC96102
0.7619 Intermediate Similarity NPC29886
0.7597 Intermediate Similarity NPC53947
0.7589 Intermediate Similarity NPC27740
0.7584 Intermediate Similarity NPC104483
0.7582 Intermediate Similarity NPC201380
0.7582 Intermediate Similarity NPC179787
0.758 Intermediate Similarity NPC129721
0.7568 Intermediate Similarity NPC105127
0.7566 Intermediate Similarity NPC86288
0.7552 Intermediate Similarity NPC471313
0.7552 Intermediate Similarity NPC471311
0.755 Intermediate Similarity NPC20144
0.7533 Intermediate Similarity NPC59084
0.7532 Intermediate Similarity NPC321911
0.7516 Intermediate Similarity NPC63545
0.7516 Intermediate Similarity NPC51054
0.75 Intermediate Similarity NPC90723
0.7483 Intermediate Similarity NPC63157
0.7483 Intermediate Similarity NPC473868
0.7468 Intermediate Similarity NPC469811
0.7451 Intermediate Similarity NPC314372
0.7434 Intermediate Similarity NPC190296
0.7432 Intermediate Similarity NPC198988
0.7429 Intermediate Similarity NPC215519
0.7421 Intermediate Similarity NPC318065
0.7421 Intermediate Similarity NPC206819
0.7417 Intermediate Similarity NPC2949
0.7417 Intermediate Similarity NPC279081
0.741 Intermediate Similarity NPC162689
0.741 Intermediate Similarity NPC54102
0.7403 Intermediate Similarity NPC288838
0.7391 Intermediate Similarity NPC478182
0.7389 Intermediate Similarity NPC325903
0.7372 Intermediate Similarity NPC24678
0.7372 Intermediate Similarity NPC105818
0.7358 Intermediate Similarity NPC286427
0.7355 Intermediate Similarity NPC477974
0.7353 Intermediate Similarity NPC235843
0.7347 Intermediate Similarity NPC82295
0.7347 Intermediate Similarity NPC471322
0.7343 Intermediate Similarity NPC122718
0.7338 Intermediate Similarity NPC285731
0.7312 Intermediate Similarity NPC41257
0.7303 Intermediate Similarity NPC230002
0.729 Intermediate Similarity NPC143872
0.7278 Intermediate Similarity NPC259644
0.7278 Intermediate Similarity NPC469786
0.7278 Intermediate Similarity NPC469765
0.7278 Intermediate Similarity NPC200214
0.7278 Intermediate Similarity NPC138842
0.7278 Intermediate Similarity NPC25008
0.7278 Intermediate Similarity NPC469760
0.7278 Intermediate Similarity NPC73952
0.7278 Intermediate Similarity NPC469763
0.7267 Intermediate Similarity NPC215584
0.7267 Intermediate Similarity NPC325252
0.7267 Intermediate Similarity NPC44773
0.725 Intermediate Similarity NPC236711
0.725 Intermediate Similarity NPC216643
0.7244 Intermediate Similarity NPC21605
0.7244 Intermediate Similarity NPC471957
0.7237 Intermediate Similarity NPC88097
0.7235 Intermediate Similarity NPC83381
0.7233 Intermediate Similarity NPC80597
0.7233 Intermediate Similarity NPC75540
0.7233 Intermediate Similarity NPC70922
0.7233 Intermediate Similarity NPC211572
0.7233 Intermediate Similarity NPC212376
0.723 Intermediate Similarity NPC324611
0.7226 Intermediate Similarity NPC159856
0.7222 Intermediate Similarity NPC470203
0.7219 Intermediate Similarity NPC65408
0.7205 Intermediate Similarity NPC293487
0.72 Intermediate Similarity NPC315617
0.72 Intermediate Similarity NPC314058
0.72 Intermediate Similarity NPC316018
0.72 Intermediate Similarity NPC316359
0.7176 Intermediate Similarity NPC83987
0.7169 Intermediate Similarity NPC201634
0.7162 Intermediate Similarity NPC22079
0.716 Intermediate Similarity NPC470204
0.7152 Intermediate Similarity NPC33421
0.7143 Intermediate Similarity NPC167635
0.7143 Intermediate Similarity NPC280852
0.7143 Intermediate Similarity NPC193740
0.7125 Intermediate Similarity NPC34844
0.7108 Intermediate Similarity NPC194411
0.7107 Intermediate Similarity NPC470823
0.7099 Intermediate Similarity NPC80681
0.7099 Intermediate Similarity NPC92796
0.7099 Intermediate Similarity NPC135141
0.7097 Intermediate Similarity NPC477977
0.7091 Intermediate Similarity NPC49954
0.7091 Intermediate Similarity NPC474561
0.7091 Intermediate Similarity NPC478183
0.7081 Intermediate Similarity NPC115049
0.7081 Intermediate Similarity NPC469785
0.7075 Intermediate Similarity NPC278451
0.7073 Intermediate Similarity NPC478184
0.7073 Intermediate Similarity NPC317105
0.7066 Intermediate Similarity NPC82331
0.7063 Intermediate Similarity NPC141926
0.7055 Intermediate Similarity NPC122141
0.7041 Intermediate Similarity NPC474958
0.7041 Intermediate Similarity NPC203754
0.7041 Intermediate Similarity NPC150048
0.7037 Intermediate Similarity NPC469762
0.7023 Intermediate Similarity NPC213774
0.7019 Intermediate Similarity NPC476219
0.7019 Intermediate Similarity NPC476297
0.7012 Intermediate Similarity NPC225018
0.7012 Intermediate Similarity NPC478185
0.7007 Intermediate Similarity NPC476140
0.7006 Intermediate Similarity NPC469525
0.7006 Intermediate Similarity NPC470440
0.7006 Intermediate Similarity NPC91895
0.7 Intermediate Similarity NPC475450
0.7 Intermediate Similarity NPC216713
0.6988 Remote Similarity NPC160105
0.6988 Remote Similarity NPC98187
0.6988 Remote Similarity NPC56233
0.6982 Remote Similarity NPC37423
0.6982 Remote Similarity NPC275305
0.697 Remote Similarity NPC311276
0.697 Remote Similarity NPC265100
0.6968 Remote Similarity NPC115611
0.6959 Remote Similarity NPC248462
0.6946 Remote Similarity NPC201700
0.694 Remote Similarity NPC471617
0.6933 Remote Similarity NPC475428
0.6933 Remote Similarity NPC469897
0.6928 Remote Similarity NPC218268
0.6928 Remote Similarity NPC274229
0.6914 Remote Similarity NPC229055
0.6909 Remote Similarity NPC124542
0.6909 Remote Similarity NPC59779
0.6909 Remote Similarity NPC471177
0.6909 Remote Similarity NPC282231
0.6905 Remote Similarity NPC32534

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC32002 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD2073 Approved
1.0 High Similarity NPD2075 Approved
1.0 High Similarity NPD2074 Approved
1.0 High Similarity NPD2072 Approved
0.916 High Similarity NPD2119 Approved
0.916 High Similarity NPD2118 Approved
0.8904 High Similarity NPD6497 Approved
0.8828 High Similarity NPD3339 Approved
0.8767 High Similarity NPD2165 Phase 1
0.8759 High Similarity NPD4029 Approved
0.8759 High Similarity NPD4030 Approved
0.8759 High Similarity NPD4028 Approved
0.8725 High Similarity NPD4384 Clinical (unspecified phase)
0.8707 High Similarity NPD3115 Approved
0.8707 High Similarity NPD3112 Approved
0.8707 High Similarity NPD3114 Approved
0.8707 High Similarity NPD3113 Approved
0.8676 High Similarity NPD3476 Approved
0.8676 High Similarity NPD3475 Approved
0.8649 High Similarity NPD2865 Clinical (unspecified phase)
0.8623 High Similarity NPD3942 Approved
0.8623 High Similarity NPD3944 Approved
0.8553 High Similarity NPD3929 Clinical (unspecified phase)
0.8451 Intermediate Similarity NPD2069 Approved
0.8451 Intermediate Similarity NPD2068 Approved
0.8451 Intermediate Similarity NPD2070 Approved
0.8451 Intermediate Similarity NPD2071 Approved
0.8451 Intermediate Similarity NPD768 Clinical (unspecified phase)
0.8442 Intermediate Similarity NPD4973 Approved
0.8425 Intermediate Similarity NPD2110 Approved
0.8321 Intermediate Similarity NPD991 Phase 2
0.8321 Intermediate Similarity NPD992 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD5541 Clinical (unspecified phase)
0.8243 Intermediate Similarity NPD5538 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD2077 Approved
0.8217 Intermediate Similarity NPD2076 Approved
0.8153 Intermediate Similarity NPD3117 Approved
0.8153 Intermediate Similarity NPD3116 Approved
0.8116 Intermediate Similarity NPD9583 Approved
0.8113 Intermediate Similarity NPD6471 Clinical (unspecified phase)
0.8092 Intermediate Similarity NPD473 Clinical (unspecified phase)
0.8069 Intermediate Similarity NPD945 Clinical (unspecified phase)
0.8028 Intermediate Similarity NPD1993 Approved
0.8028 Intermediate Similarity NPD1995 Approved
0.8028 Intermediate Similarity NPD1994 Approved
0.8027 Intermediate Similarity NPD2007 Clinical (unspecified phase)
0.8015 Intermediate Similarity NPD268 Approved
0.8015 Intermediate Similarity NPD271 Approved
0.8015 Intermediate Similarity NPD270 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD715 Phase 3
0.7987 Intermediate Similarity NPD7216 Approved
0.7987 Intermediate Similarity NPD7217 Approved
0.7971 Intermediate Similarity NPD9357 Approved
0.7959 Intermediate Similarity NPD1722 Approved
0.7933 Intermediate Similarity NPD4702 Approved
0.7933 Intermediate Similarity NPD4547 Phase 3
0.7933 Intermediate Similarity NPD4703 Approved
0.7867 Intermediate Similarity NPD7469 Discontinued
0.7847 Intermediate Similarity NPD3385 Approved
0.7785 Intermediate Similarity NPD2006 Phase 2
0.7778 Intermediate Similarity NPD2771 Approved
0.7763 Intermediate Similarity NPD2430 Phase 2
0.7744 Intermediate Similarity NPD4823 Approved
0.7744 Intermediate Similarity NPD4824 Approved
0.7733 Intermediate Similarity NPD1918 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD6217 Discontinued
0.7711 Intermediate Similarity NPD5892 Approved
0.7703 Intermediate Similarity NPD786 Approved
0.7692 Intermediate Similarity NPD2373 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3654 Approved
0.7676 Intermediate Similarity NPD1598 Discontinued
0.7671 Intermediate Similarity NPD2140 Approved
0.7671 Intermediate Similarity NPD2142 Approved
0.7671 Intermediate Similarity NPD2141 Approved
0.7647 Intermediate Similarity NPD3100 Discontinued
0.7634 Intermediate Similarity NPD9098 Phase 3
0.7634 Intermediate Similarity NPD9099 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD198 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD2837 Discontinued
0.7591 Intermediate Similarity NPD9396 Approved
0.7591 Intermediate Similarity NPD9392 Approved
0.758 Intermediate Similarity NPD2582 Approved
0.758 Intermediate Similarity NPD2581 Approved
0.7574 Intermediate Similarity NPD269 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD748 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD3717 Discontinued
0.755 Intermediate Similarity NPD4510 Discontinued
0.7547 Intermediate Similarity NPD5315 Discontinued
0.7532 Intermediate Similarity NPD5255 Approved
0.753 Intermediate Similarity NPD3927 Phase 2
0.7516 Intermediate Similarity NPD1248 Discontinued
0.75 Intermediate Similarity NPD792 Discontinued
0.75 Intermediate Similarity NPD3323 Discontinued
0.75 Intermediate Similarity NPD2012 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD4891 Phase 2
0.7485 Intermediate Similarity NPD4011 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD2466 Phase 3
0.7484 Intermediate Similarity NPD2462 Phase 3
0.7484 Intermediate Similarity NPD2465 Approved
0.7434 Intermediate Similarity NPD4637 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD4374 Clinical (unspecified phase)
0.74 Intermediate Similarity NPD2896 Discontinued
0.7386 Intermediate Similarity NPD3813 Approved
0.7384 Intermediate Similarity NPD6133 Discontinued
0.7372 Intermediate Similarity NPD2172 Phase 1
0.7362 Intermediate Similarity NPD7287 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD4779 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD2641 Approved
0.7362 Intermediate Similarity NPD2640 Approved
0.7356 Intermediate Similarity NPD4528 Approved
0.7356 Intermediate Similarity NPD4526 Approved
0.7356 Intermediate Similarity NPD4529 Approved
0.7355 Intermediate Similarity NPD1661 Suspended
0.7353 Intermediate Similarity NPD3771 Phase 3
0.7342 Intermediate Similarity NPD977 Approved
0.7342 Intermediate Similarity NPD976 Approved
0.7342 Intermediate Similarity NPD975 Approved
0.7333 Intermediate Similarity NPD4112 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD45 Approved
0.7333 Intermediate Similarity NPD4524 Discontinued
0.7333 Intermediate Similarity NPD6554 Approved
0.7329 Intermediate Similarity NPD6771 Discontinued
0.7325 Intermediate Similarity NPD4641 Discontinued
0.7308 Intermediate Similarity NPD1183 Approved
0.7305 Intermediate Similarity NPD2731 Phase 2
0.7297 Intermediate Similarity NPD1627 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD2580 Discontinued
0.729 Intermediate Similarity NPD6148 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD1380 Discovery
0.7273 Intermediate Similarity NPD3610 Approved
0.7273 Intermediate Similarity NPD3401 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3362 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD3609 Approved
0.7267 Intermediate Similarity NPD1255 Approved
0.7267 Intermediate Similarity NPD1254 Approved
0.7267 Intermediate Similarity NPD1253 Approved
0.7267 Intermediate Similarity NPD1256 Approved
0.7255 Intermediate Similarity NPD5020 Approved
0.7246 Intermediate Similarity NPD4385 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD409 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD2385 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1937 Approved
0.7219 Intermediate Similarity NPD200 Phase 2
0.7219 Intermediate Similarity NPD201 Phase 2
0.7205 Intermediate Similarity NPD5418 Discontinued
0.719 Intermediate Similarity NPD3943 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD165 Phase 2
0.7179 Intermediate Similarity NPD1683 Approved
0.7175 Intermediate Similarity NPD4848 Phase 1
0.7163 Intermediate Similarity NPD3499 Approved
0.7163 Intermediate Similarity NPD3498 Approved
0.7161 Intermediate Similarity NPD5671 Approved
0.7161 Intermediate Similarity NPD4509 Discontinued
0.716 Intermediate Similarity NPD6454 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2511 Approved
0.7153 Intermediate Similarity NPD2940 Approved
0.7153 Intermediate Similarity NPD2938 Approved
0.7152 Intermediate Similarity NPD4639 Approved
0.7152 Intermediate Similarity NPD5862 Discovery
0.7152 Intermediate Similarity NPD4638 Approved
0.7152 Intermediate Similarity NPD2390 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD4640 Approved
0.7143 Intermediate Similarity NPD1192 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1383 Phase 3
0.7143 Intermediate Similarity NPD1382 Phase 2
0.7143 Intermediate Similarity NPD6375 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD5213 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2730 Approved
0.7126 Intermediate Similarity NPD2728 Approved
0.7126 Intermediate Similarity NPD2729 Approved
0.7125 Intermediate Similarity NPD2809 Approved
0.7118 Intermediate Similarity NPD6514 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD6515 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD1853 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD5400 Approved
0.7114 Intermediate Similarity NPD803 Phase 1
0.7107 Intermediate Similarity NPD3262 Approved
0.7101 Intermediate Similarity NPD7111 Discontinued
0.7101 Intermediate Similarity NPD4181 Approved
0.7099 Intermediate Similarity NPD3433 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD3361 Phase 1
0.7089 Intermediate Similarity NPD3852 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD1561 Phase 2
0.7083 Intermediate Similarity NPD5787 Discontinued
0.7076 Intermediate Similarity NPD4383 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD3583 Phase 2
0.7069 Intermediate Similarity NPD2770 Discontinued
0.7066 Intermediate Similarity NPD5934 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD5472 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD1404 Approved
0.7055 Intermediate Similarity NPD1403 Approved
0.7052 Intermediate Similarity NPD2868 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5254 Discontinued
0.7045 Intermediate Similarity NPD4699 Discontinued
0.7035 Intermediate Similarity NPD4345 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD6194 Discontinued
0.7033 Intermediate Similarity NPD3931 Approved
0.7033 Intermediate Similarity NPD3928 Approved
0.703 Intermediate Similarity NPD2719 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD2782 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data